Home Institutions UCSF clinical trials Institution Directory
Clinical trials at UCSF Sites in San Francisco, CA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Nov 2, 2026, 10:46 PM EST
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1393
Current sort
Recently updated
Campus scope
UCSF, San Francisco, CA
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 1021–1032 of 1,393 matching trials with a site at UCSF, San Francisco, CA.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Hidradenitis Suppurativa
Interventions Not listed
Lead sponsor University of California, San Francisco Other
Eligibility 10 Years and older
Enrollment 3,000 participants
Timeline 2020 – 2035
U.S. locations 1
States / cities San Francisco, California
Conditions Osteoarthritis, Rheumatoid Arthritis, Post-traumatic Arthritis, Ununited Humeral Head Fracture, Irreducible 3-and 4-part Proximal Humeral Fractures, Avascular Necrosis, Gross Rotator Cuff Deficiency, Revision Total Shoulder Arthroplasty
Interventions Trabecular Metal Reverse Shoulder System Device
Lead sponsor Zimmer Biomet Industry
Eligibility 18 Years and older
Enrollment 200 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2011 – 2026
U.S. locations 4
States / cities San Francisco, California • Louisville, Kentucky • Egg Harbor, New Jersey + 1 more
Conditions Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC), Advanced Solid Tumors
Interventions REGN10597, Cemiplimab Drug
Lead sponsor Regeneron Pharmaceuticals Industry
Eligibility 18 Years and older
Enrollment 240 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2030
U.S. locations 11
States / cities Los Angeles, California • San Francisco, California • North Haven, Connecticut + 7 more
Conditions AMD, nAMD, Wet Age-related Macular Degeneration, wAMD, Wet AMD, CNV, Neovascular AMD, Neovascular Age-related Macular Degeneration, Choroidal Neovascularization
Interventions ABBV-RGX-314, Ranibizumab (LUCENTIS®) Genetic · Biological
Lead sponsor AbbVie Industry
Eligibility 50 Years to 89 Years
Enrollment 671 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 89
States / cities Phoenix, Arizona • Sun City, Arizona • Little Rock, Arkansas + 77 more
Conditions Heart Failure and Reduced Ejection Fraction
Interventions Online, patient-facing decision-making aid (app) with personalized risk information., Implantable Cardioverter Defibrillator (ICD), Online, patient-facing decision-making app without personalized risk information. Other · Device
Lead sponsor Stanford University Other
Eligibility 60 Years and older
Enrollment 600 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 2
States / cities San Francisco, California • Greenville, North Carolina
Conditions Uterine Fibroids
Interventions Radiofrequency ablation of fibroids, Myomectomy of fibroids Procedure
Lead sponsor University of California, San Francisco Other
Eligibility 21 Years and older · Female only
Enrollment 578 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2014 – 2026
U.S. locations 12
States / cities Irvine, California • San Diego, California • San Francisco, California + 9 more
Conditions Advanced Solid Tumors, NSCLC Adenocarcinoma, Cholangiocarcinoma, Pancreatic Carcinoma, Colorectal Carcinoma
Interventions MGC028 Biological
Lead sponsor MacroGenics Industry
Eligibility 18 Years and older
Enrollment 124 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 7
States / cities San Francisco, California • Boston, Massachusetts • Grand Rapids, Michigan + 3 more
Conditions Small-Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Carcinoma of the Lung
Interventions 225Ac-ABD147 Drug
Lead sponsor Abdera Therapeutics Inc. Industry
Eligibility 18 Years and older
Enrollment 17 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 12
States / cities Newport Beach, California • San Francisco, California • Santa Monica, California + 9 more
Conditions Breast Cancer
Interventions Abemaciclib, Standard Adjuvant Endocrine Therapy Drug
Lead sponsor Eli Lilly and Company Industry
Eligibility 18 Years and older
Enrollment 5,637 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2029
U.S. locations 162
States / cities Birmingham, Alabama • Anchorage, Alaska • Gilbert, Arizona + 104 more
Conditions Toxicant Exposure, Firefighter, Occupational Exposure to Chemicals
Interventions Colesevelam, Placebo Drug
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years and older · Male only
Enrollment 50 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2028
U.S. locations 1
States / cities San Francisco, California
Conditions Hemophagocytic Lymphohistiocytosis
Interventions Ruxolitinib, Dexamethasone, Etoposide Drug
Lead sponsor St. Jude Children's Research Hospital Other
Eligibility 6 Weeks to 22 Years
Enrollment 10 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2026
U.S. locations 13
States / cities Phoenix, Arizona • Orange, California • San Francisco, California + 10 more
Conditions Asthma
Interventions Not listed
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years to 70 Years
Enrollment 24 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2024 – 2028
U.S. locations 1
States / cities San Francisco, California About this UCSF institution page
What this page lists ClinicalTrials.gov records that list UCSF in San Francisco, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by University of California, San Francisco at any site , browse by condition , or browse by U.S. city .